Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: 0.50 (7.41%)
Spread: 0.50 (7.143%)
Open: 6.75
High: 7.25
Low: 6.75
Prev. Close: 6.75
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment update – Phasefocus Holdings Limited

31 May 2023 07:00

RNS Number : 0789B
Braveheart Investment Group plc
31 May 2023
 

31 May 2023

Braveheart Investment Group plc

("Braveheart", the "Company" or the "Group")

 

Investment update - Phasefocus Holdings Limited

 

Braveheart Investment Group (AIM: BRH), announces an update on Phasefocus Holdings Limited ("Phasefocus"), a company within Braveheart's investment portfolio and in which the Company has a 44.2% holding.

 

Phasefocus' imaging and analysis system, Livecyte®, uses a novel method for high fidelity quantitative imaging and microscopy; this is known in the scientific literature as "ptychography".

 

Phasefocus recently appointed Nexus Scientific, a specialist in cell analysis instrument sales, to represent Livecyte® products in North America. Over the coming months, Nexus will be running a series of customer workshops, conference attendances and seminars, with the object of raising the profile and sales of Livecyte® in the USA.

 

Dr. Peter Djali has been appointed as Phasefocus's Head of European Business Development. Peter has previously held senior commercial roles in a range of biotech instrumentation companies, including Lumicks, CytoSMART, Isoplexis and Essen Bioscience. He brings with him a wealth of market sector experience and relevant potential customer connections. Peter will be building Phasefocus's sales channel network within Europe.

 

In April and May, Martin Humphry, CEO of Phasefocus, visited its distributors in Japan, China and the USA to raise the profile of Phasefocus and meet many potential customers.

 

Two new Livecyte® applications have been developed and are scheduled for launch before the end of 2023. These will be marketed as proprietary assays, to meet the needs of cell biologists testing drug performance in immuno-oncology and neurosciense applications. Livecyte® users have the ability to continuously track thousands of individual cells and sustain cell health and viability over prolonged durations. This fundamental feature facilitates longitudinal studies involving live cells, thereby permitting a more thorough exploration of dynamic cellular processes and the efficacy of drugs on them.

 

Trevor Brown, Chief Executive Officer of Braveheart, commented:

 

"Phasefocus has gained momentum in a number of areas recently which your Board is hopeful will lead to increased sales over the coming months."

 

For further information:

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, Chief Executive Officer

Viv Hallam, Executive Director

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

James Reeve / George Payne

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDZGFKVGZGFZM
Date   Source Headline
25th Jan 20137:00 amRNSEnvestors sets Fertility Focus on growth path
31st Dec 201211:15 amRNSTotal Voting Rights
19th Dec 20124:00 pmRNSIssue of Equity
14th Dec 20127:00 amRNSEnvestors members invest in eReceipts
4th Dec 20127:00 amRNSCyCell dials up Envestors for growth funding
3rd Dec 20127:00 amRNSHalf Yearly Report
28th Sep 20127:00 amRNSEnvestors closes equity funding round for Capablue
26th Sep 20127:00 amRNSAward of options
25th Sep 20122:49 pmRNSResult of AGM
4th Sep 20127:00 amRNSAward of options
31st Aug 20127:00 amRNSNotice of AGM
30th Aug 20127:00 amRNSEnvestors closes MoBank funding
29th Aug 20127:00 amRNSMandate to manage Lachesis Fund
13th Aug 20127:00 amRNSPreliminary Results
29th Jun 20127:00 amRNSChange of Adviser
27th Jun 20127:00 amRNSmLED secures further equity backing
11th Jun 20127:00 amRNSAward of fund management contract
31st May 201212:58 pmRNSDirector/PDMR Shareholding
31st May 20127:00 amRNSEnvestors deal backs Squease
29th May 20127:00 amRNSDirector/PDMR Shareholding
28th May 20129:00 amRNSDirector/PDMR Shareholding
28th May 20129:00 amRNSGrant of Options
18th May 20127:00 amRNSUpdate - appointment to manage £50m loan fund
11th May 20127:00 amRNSIssue of equity and placing of shares
8th May 20127:00 amRNSEnvestors closes Style-Passport funding
18th Apr 20127:00 amRNSEnvestors launches Isle of Man service
5th Apr 20127:00 amRNSIssue of Equity and Placing of Shares
23rd Mar 20127:00 amRNSAcquisition
21st Mar 20127:00 amRNSAppointment of joint broker
29th Feb 20127:00 amRNSAppointment to manage £50m loan fund
29th Dec 20117:00 amRNSHalf Yearly Report
22nd Dec 20117:00 amRNSFurther investment in AppShare
20th Dec 20117:00 amRNSFurther investment in Conjunct
8th Dec 20117:00 amRNSEnvestors secures Cherrygood funding
24th Nov 20117:00 amRNSEnvestors secures £450,000 eReceipts funding
10th Nov 20117:00 amRNSE-learning transaction
23rd Sep 20117:00 amRNSFurther investment in Chargemaster Plc
15th Sep 20113:10 pmRNSResult of AGM
7th Sep 20117:00 amRNSInvestment in Olly Limited
22nd Aug 20117:00 amRNSNotice of AGM
19th Aug 20117:00 amRNSFurther investment in Design LED Products
26th Jul 20117:00 amRNSFinal Results
22nd Jul 20117:00 amRNSNotice of Results
1st Jul 20114:06 pmRNSHolding(s) in Company
1st Jul 20113:58 pmRNSHolding(s) in Company
29th Jun 20117:00 amRNSDevelopment of business angel network
27th Jun 201111:39 amRNSHolding(s) in Company
27th Jun 201111:38 amRNSHolding(s) in Company
23rd Jun 20117:00 amRNSIssue of equity and placing of shares
17th May 20117:00 amRNSInvestment in Surface Generation Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.